LVAD offers a stable platform to help patients overcome barriers to heart transplant. In one cohort, ~70% had modifiable barriers and 60% of these resolved at least one after LVAD, highlighting the role of multidisciplinary care.🫀📊 🔗 https://bit.ly/4uPEHUy

Cardiogenic shock → low CO & end-organ hypoperfusion. LV failure is common, but don’t miss other causes: valvular disease, mechanical MI complications, or RV failure. A systematic approach + bedside echo can rapidly guide diagnosis and escalation.🫀 🔗 https://bit.ly/4uPBSTs

JCF Intersections is out now! Where research meets perspective, and new ideas take shape across disciplines. Explore the latest 👉 https://www.onlinejcfi.org/current #HeartFailure #Cardiology

Collaboration between HF clinicians, investigators, entrepreneurs & investors is key to solving unmet needs. Venture-backed innovation has driven advances from meds to devices, permitting HF cardiologists to shape patient-centric diagnostics & therapies. 🔗 https://bit.ly/4qX4KWU

An 🛜 online, asynchronous curriculum improved critical-care trainees’ knowledge📚 of MCS devices, beyond what clinical exposure alone provided. Gains were strongest for LVAD management. Next step is assessing knowledge transfer into clinical setting🏥. 🔗 https://bit.ly/3NWnF5Z

New science 🚨! In pts on pV-A ECMO, 20% developed de novo AF ❤️‍🩹. dnAF was linked to longer ECMO duration (6.4 vs 3.6 days) & ⬆️post-decannulation in-hospital mortality (33% vs 20%). PADP elevation trended toward ⬆️dnAF risk. 🔗 https://bit.ly/4r5dkTx

Analyzing HFrEF & HFmrEF pts from the TriNetX cohort, metoprolol succinate was associated with ⬆️ event-free survival than tartrate, driven by ⬇️ hospitalizations & deaths. Results support guideline preference for succinate due to more consistent β1 blockade. 🔗 https://bit.ly/4jO2oau

A HFrEF polypill💊 could ⬆️ GDMT uptake, but prescriber prefs are unknown. Using a 5-stage mixed-methods process, researchers built a discrete choice experiment to test cardiologists’ prefs—work that will directly inform future HFrEF polypill clinical trials. 🔗 https://bit.ly/3ZmjsLp

New science 🚨! In an analysis of centrifugal-flow LVAD trials, digoxin💊 users showed greater improvement in 6MWT 🚶 vs no digoxin (especially in older pts) with similar QOL & AE rates. Digoxin was also linked to better 4-yr survival in NICM pts. 🔗 https://bit.ly/4r5phsy

📣 Last chance to sign up for Office Hours! Join Editor in Chief Dr. Katz and Deputy Editor Dr. Reza to answer your questions on: ✅ JCF-I's upcoming publications ✅ What they are looking for in submissions ✅ Updates on the year ahead 📆 Wednesday, January 28th 🕐 12:00PM - 1:00PM 🔗 bit.ly/3NmOKz4

The January issue of JCF-I is now available 👉 bringing forward new evidence, perspectives, and conversations in heart failure + various intersections. Read the full issue 📖 https://www.onlinejcfi.org/current

Time is running out! Register for JCF-I Office Hours⌛ Join Editor in Chief Dr. Katz and Deputy Editor Dr. Reza to answer your questions on: ✅ JCF-I's upcoming publications ✅ What they are looking for in submissions ✅ Updates on the year ahead bit.ly/3NmOKz4

🚨 JCF-I Office Hours Join Editor in Chief Dr. Katz and Deputy Editor Dr. Reza to answer your questions on: ✅ JCF-I's upcoming publications ✅ What they are looking for in submissions ✅ Updates on the year ahead 📆 Wednesday, January 28th 🕐 12:00PM - 1:00PM Register 🔗: https://bit.ly/3NmOKz4

📢 New study in JCF-I on the safety and effectiveness of a low-carbohydrate ketogenic diet LCKD for weight loss in patients with overweight/obesity and HF. This is one of the largest real-world looks at LCKD use in HF. 🫀🍽️ See below ⬇️ bit.ly/3Ka9yZz

How well can the right ventricle rise to the challenge? 💪💙 A new JCF-Intersections paper reviews right ventricular reserve (RVR) — the RV’s ability to boost output under stress. 🧵

💡 CABG or PCI? A new perspective on value in ischemic cardiomyopathy. New #JCFIntersections study on cost-effectiveness analysis comparing CABG + OMT vs PCI + OMT is here. 🔗 Read in Journal of Cardiac Failure – Intersections: bit.ly/48oKsze #HeartFailure

📢 Editorial Spotlight in JCF–Intersections: “Getting with the Guidelines: Improving Quality of Hospital Care in Atrial Fibrillation and Heart Failure” by Drs. Ifunanyachukwu Okwuosa, Enat Arega, and Utibe Essien. bit.ly/4hyklZR Read more 🧵

🚀 Issue 2 is live! JCF-Intersections continues to explore how collaboration and diversity shape the future of heart failure care. 💡 Discover more: https://onlinejcfi.org/current

✨Key editorial JCF–I! “Sex Differences in Cardiogenic Shock Supported w/ VA-ECMO” Highlights: 🚺Women often present sicker + receive ECMO later 🚫Less likely to receive LV venting ⚖️Despite this, survival = comparable to men 📈Urgent need to address systemic inequities in shock care 📖 bit.ly/4hyfXKn

🧬 Editorial highlight in JCF-Intersections: barriers + opportunities for TTR genetic testing in ATTR amyloidosis ➡️ Cascade testing + counseling are critical for early diagnosis + family care. Read here: http://bit.ly/4qqST4h #CardioTwitter #HeartFailure #Amyloidosis

📊New study explores how 🌍Social Vulnerability Index (SVI) & Social Deprivation Index (SDI) impact HF hospitalizations. 🏥Counties with higher social vulnerability & deprivation → ⬆️ HFH rates. SVI & SDI could help identify vulnerable populations! 🔗https://bit.ly/4omF6di #AHA2025

ICYMI: Featured in JCF-Intersections inaugural issue: Post-hoc AFFIRM analysis on association between AAD-based rhythm control and mortality risk in AF + HFpEF, despite improved sinus rhythm. ➡️ Calls for modern trials w/ catheter ablation + GDMT. 🔗: bit.ly/4hqDvAw #HeartFailure #AFib #HFpEF

📊 In JCF–I: VA-ECMO in cardiogenic shock: are sex differences clinically meaningful? 👩‍⚕️ Women had: ✅ Less RRT ✅ More favorable SAVE scores 📉 But similar in-hospital mortality to men This data may inform personalized treatment strategies in mechanical circulatory support. 🔗 bit.ly/4pydpzu

What makes the biggest difference in CICU survival? Staffing. 👨‍⚕️👩‍⚕️ Thomas & Flint call for structured training, better resource allocation, & future-forward triaging systems. 🚑 🔗 bit.ly/4psSrSh #Cardiology #CICU #CriticalCareCardiology #JCFIntersections

🚨 New in JCF–Intersections! How can we make trials in cardiogenic shock feasible & impactful? Our latest JCF–Intersections review highlights the DOREMI experience, showing how training programs + mentorship fuel pragmatic trainee-led trials in the CICU. Read more 👇

🫀 New in JCF–Intersections: What’s the impact of staffing models in the CICU? Our newest published meta-analysis shows: High-intensity staffing reduces in-hospital & CICU mortality The benefit is strongest in intensivist-led care Full article: http://bit.ly/4n9GNdK #Cardiology #CriticalCare

We are excited to bring you the first issue of JCF-Intersections, where you will find important contributions that embrace and harness the concept of intersections within medicine in their own distinct and powerful ways. 🫀 Read now: https://www.onlinejcfi.org/current

📣 Exciting news: The inaugural issue of JCF–Intersections drops tomorrow! Hear from Dr. Jason Katz & Dr. Nosheen Reza as they share their vision for this new platform in heart failure research & care. 🎥 https://youtu.be/njAjznbE0BY #Cardiology #MedicalResearch #JCFIntersections

New in JCF–I: TOPCAT imaging sub-study (N=211) shows no association between diastolic echo changes & KCCQ health status in HFpEF. 🧠 Patient-reported outcomes may better reflect treatment response 🔗 https://bit.ly/3JVsz1d #HFpEF #Echo #PatientReportedOutcomes #CardioBlueSky #JCFIntersections

New in JCF–I 📰 This national survey of advanced heart failure and transplant cardiologists & surgeons reveals insights on perceived gender diversity and discrimination in the field. 🔗 bit.ly/4motlCr 🧵Key findings ⬇️

Join Editor in Chief Dr. Jason Katz and Deputy Editor Dr. Nosheen Reza for JCF-I Office Hours! Answering your questions on: ✅ the journal’s inaugural publications ✅what they are looking for in submissions ✅exciting updates on what’s to come Registration 🔗 http://bit.ly/3Hu9SRo

RRT use in CICU patients with cardiogenic shock = higher in-hospital & 1-year mortality. 🚨 CRRT patients: 📉 56% in-hospital mortality 📉 <30% 1-year survival ⚠️ Only 1 in 5 survive 1 year free from dialysis This study underscores the prognostic weight of AKI and RRT modality. 🔗 bit.ly/3Utjz5w

JCF-Intersections welcomes diverse perspectives on the intersections of cardiovascular patient care. Submit your work today! 🗳️ Information for Authors: bit.ly/40hRwt7 #Cardiology #HeartFailure

What drives patients with ATTR-CM and families to pursue genetic testing? 🧬 ✨ Provider trust & duty to family were top motivators 🧠 Patients wanted more info on risks, esp. insurance 📉 Testing was easy, but emotionally taxing 🤝Clear need for better consent, counseling & support. 🔗 bit.ly/4lWnlAt

Have groundbreaking research on the intersections of patient care? Submit to JCF-Intersections and contribute to the global conversation 🌎 Information for Authors: https://bit.ly/40hRwt7 #Cardiology #HeartFailure

🩺 New in JCF–I: CKM syndrome is a leading cause of cardiovascular disease, yet our care systems remain fragmented. 🔹 An integrated practice model 🔹 Stage-based risk pathways 🔹 Scalable, tech-enabled care 🔹 Value-based reimbursement strategies 🔗 bit.ly/3IK7lTB

🚨 The inaugural publication in JCF–Intersections is here! AFFIRM sub-analysis: ✅ AADs effective for sinus rhythm in HFpEF ⚠️ Class Ic & sotalol ↑ mortality ✔️ Amiodarone may be safer A strong call for HFpEF recognition & precision in rhythm control. 🔗 www.onlinejcfi.org/article/S305...

Real-world wisdom, distilled. “Teachable Moments” in JCF-Intersections features practical insights from the frontlines of heart failure care — submit today: bit.ly/44I4YYE #MedicalEducation #HeartFailure #Cardiology

🩺 Ready to publish with JCF-Intersections? Whether you're innovating in training, sharing clinical pearls, or sparking a debate—there's a section for your voice. Submit today: https://bit.ly/44I4YYE 💡 Training | ⚕️ Teachable Moments | ⚖️ Debates #MedEd #HeartFailure #Cardiology

Collaboration is key in advancing heart failure care. Share your research with JCF-Intersections and be part of a global community. Information for Authors: Journal of Cardiac Failure - Intersections: 🔗http://bit.ly/3IifiPi #Cardiology #HeartFailure

We’re cultivating exciting new opportunities for scientific dialogue at JCF-Intersections! What would you like to see in our inaugural issues? ✅ Debates on Hot Topics ✅ Clinical Pearls ✅ Patient Perspectives Something else? Let us know in the comments🗳️

Have a breakthrough at the intersection of heart failure and cardiovascular care? Share it with JCF-Intersections and contribute to the global medical community. Information for Authors: Journal of Cardiac Failure - Intersections: 🔗 http://bit.ly/3IifiPi #Cardiology #HeartFailure

Join the conversation on the intersections between heart failure and cardiovascular care with JCF-Intersections. Follow us for the latest updates and discussions. #Cardiology #HeartFailure

Join the JCF-Intersections community and contribute to the dialogue on intersections of cardiovascular care. Information for Authors: Journal of Cardiac Failure - Intersections: 🔗http://bit.ly/3IifiPi #Cardiology #HeartFailure

At JCF-Intersections, we believe in cultivating collaborations at the intersections of heart failure, cardiovascular medicine, and beyond. Let's work together to bridge across silos to advance patient care! #Cardiology #HeartFailure #HeartFunction

Share your "How I Do It"! JCFI’s “Teachable Moments” highlights expert perspectives on advanced HF practice — real lessons from real clinicians! 📌 1000–1200 words, up to 5 references Submit Today: https://bit.ly/3FT5o6e #MedicalEducation #HeartFailure #Cardiology

Your research matters. Share it with JCF-Intersections and make an impact at the intersections of care. Submit your research today at: https://www.editorialmanager.com/jcf-i/default2.aspx #Cardiology #HeartFailure

How would you reimagine HF training? JCF-I highlights trailblazing approaches in advanced HF ed- from AI fellowships to palliative integration. We want your story. 🧠 Word count: 1000–1500 📊 Up to 2 figures Submit your paper today! bit.ly/3FT5o6e #CardioEd #HeartFailure #Cardiology

Two Takes, One Conversation. It’s Up For Debate invites authors to explore advanced HF controversies—opposing perspectives welcome. Submit paired manuscripts (750–1000 words) on timely clinical or research issues. Submit Today: www.editorialmanager.com/jcf-i/defaul... #HeartFailure #Cardiology

Call for Submissions: JCF-Intersections’ Intersections in Training seeks stories of innovation in heart failure education—AI integration, novel fellowships, cross-discipline collabs. Word limit: 1,500. Submit here: https://www.editorialmanager.com/jcf-i/default2.aspx #CardioEd #HeartFailure